Moody’s downgrades Dow to Baa2 from Baa1; outlook negative

Published 07/07/2025, 20:52
© Reuters.

Investing.com -- Moody’s Ratings has downgraded The Dow Chemical (NYSE:DOW) Company’s senior unsecured credit rating to Baa2 from Baa1 while affirming its Prime-2 short term rating for commercial paper. The rating outlook remains negative.

The downgrade, announced Monday, reflects Dow’s depressed earnings and weakened credit metrics amid a prolonged market downturn. Moody’s cited governance concerns as a key driver, particularly Dow’s history of elevated dividend payouts and share repurchases despite weakened earnings performance.

Moody’s expects Dow’s earnings to decline further in 2025 from already low 2024 levels due to lower selling prices, unfavorable feedstock costs, and restructuring expenses. The rating agency noted that demand is currently depressed by weak construction and industrial activities amid high U.S. interest rates, a sluggish property sector in China, and subdued industrial activities in Europe.

Dow’s credit metrics have deteriorated significantly over the past three years, with adjusted Net debt/EBITDA rising to 5.2x at the end of March 2025, compared to 1.9x at the end of 2022. Moody’s expects these metrics to remain depressed for several more quarters before improving with a demand recovery.

For 2025, Dow’s management expects nearly $6 billion in cash support, including at least $2.4 billion from infrastructure assets divestiture, $1 billion less capital expenditure by delaying the Path2Zero project, an anticipated $1 billion award from Nova litigation, and $1 billion in annualized cost reduction.

Dow’s credit profile benefits from its large business scale, operational diversity, vertical integration into key commodity petrochemicals, and strong market positions in chemicals used in construction and packaging industries. The company also maintains excellent liquidity with $1.5 billion in cash, $340 million in marketable securities, and $8.4 billion in available credit facilities as of March 31, 2025.

The negative outlook reflects expectations of slow recovery in chemical demand, weaker earnings, resulting negative free cash flow, and elevated debt leverage over the next 12-18 months.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.